Contact
searchSearch
HMP Global
Login

Advertisement

ADVERTISEMENT

News

News
Dementia Risk More than Doubled in Patients With Schizophrenia
10/25/2022
The risk of dementia in people with schizophrenia or other psychotic disorders is 2.52 times higher than the risk of those without a psychotic disorder, according to results from a new systematic review and meta-analysis published in...
The risk of dementia in people with schizophrenia or other psychotic disorders is 2.52 times higher than the risk of those without a psychotic disorder, according to results from a new systematic review and meta-analysis published in...
The risk of dementia in people...
10/25/2022
Psych Congress Network
News
ECT Treatment More Effective for MDD Than Ketamine
10/24/2022
Each treatment, however, was found to have its own set of unique adverse effects.
Each treatment, however, was found to have its own set of unique adverse effects.
Each treatment, however, was...
10/24/2022
Psych Congress Network
News
Stimulant Shortage the Result of a “Perfect Storm”
10/21/2022
Why is there a stimulant shortage? As ADHD Section Editor Vladimir Maletic, MD, MS, explains, it's the result of a "perfect storm" of factors in 2022.
Why is there a stimulant shortage? As ADHD Section Editor Vladimir Maletic, MD, MS, explains, it's the result of a "perfect storm" of factors in 2022.
Why is there a stimulant...
10/21/2022
Psych Congress Network

Advertisement

News
Major Depressive Episode Remission Faster with BD, Longest with BPD
10/20/2022
Compared with unipolar depression, the time to remission of a major depressive episode (MDE) was shorter in patients with bipolar depression.
Compared with unipolar depression, the time to remission of a major depressive episode (MDE) was shorter in patients with bipolar depression.
Compared with unipolar...
10/20/2022
Psych Congress Network
News
Deep Brain Stimulation a Promising Treatment for OCD, Study Finds
10/20/2022
This treatment saw a 47% reduction in Y-BOCS scores in patients.
This treatment saw a 47% reduction in Y-BOCS scores in patients.
This treatment saw a 47%...
10/20/2022
Psych Congress Network
News
Study Finds Rise in Major Depressive Episodes, but Not Treatment, in Older Adults
10/19/2022
The estimated prevalence of a major depressive episode among older US adults increased 60% between 2010-2011 and 2018-2019, according to a study published in the Journal of Affective Disorders.
The estimated prevalence of a major depressive episode among older US adults increased 60% between 2010-2011 and 2018-2019, according to a study published in the Journal of Affective Disorders.
The estimated prevalence of a...
10/19/2022
Psych Congress Network

Advertisement

News
Stigma Undermines Care for Patients With Borderline Personality Disorder
10/18/2022
People with borderline personality disorder and their carers/families face structural problems in health care, including stigma and limited public health services, according to findings published in the International Journal of Mental Health...
People with borderline personality disorder and their carers/families face structural problems in health care, including stigma and limited public health services, according to findings published in the International Journal of Mental Health...
People with borderline...
10/18/2022
Psych Congress Network
From DepressionCare360
Adjunctive D-Cycloserine Improves Efficacy of Brain Stimulation in Patients with MDD
10/17/2022
Adding D-cycloserine to intermittent TBS significantly improved outcomes in patients with MDD.
Adding D-cycloserine to intermittent TBS significantly improved outcomes in patients with MDD.
Adding D-cycloserine to...
10/17/2022
Psych Congress Network
News
Experts Share 2 Top Tools for Peer Support in Psychedelics
10/14/2022
Techniques to make this therapeutic tool more effective and help build connection with patients.
Techniques to make this therapeutic tool more effective and help build connection with patients.
Techniques to make this...
10/14/2022
Psych Congress Network

Advertisement

News
Dementia Diagnosis Associated With Increased Suicide Risk in Certain Subgroups
10/13/2022
The association was found in patients under 65 years, recently diagnosed, and those with psychiatric comorbidities.
The association was found in patients under 65 years, recently diagnosed, and those with psychiatric comorbidities.
The association was found in...
10/13/2022
Psych Congress Network

Advertisement

Advertisement

Advertisement

Advertisement

NEW FROM THE NP INSTITUTE ONLINE LEARNING HUB

andrew and julie
Rapid Refresh
Navigating Bipolar Disorder Treatment: Exploring the Role of Second-Generation Antipsychotics
04/11/2024

Featuring Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN

Featuring Andrew Penn, MS, PMHNP, and...
Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...
Andrew Penn, MS, PMHNP, and Julie Carbray, PhD, FPMHNP-BC, PMHCNS-BC, APRN, explore the nuanced role of second-generation antipsychotics in bipolar disorder treatment. They discuss the complexities of managing mania and depression phases and...
Andrew Penn, MS, PMHNP, and...
04/11/2024
Psych Congress NP Institute
Amber Hoberg
Rapid Refresh
Long-Acting Injectables for Adolescents With Schizophrenia and Schizoaffective Disorder
04/10/2024
Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...
Amber Hoberg, PMHNP-BC, navigates the complexities of adolescent psychosis treatment, exploring the potential benefits and considerations of LAIs for schizophrenia and schizoaffective disorder, while emphasizing evidence-based practice for...
Amber Hoberg, PMHNP-BC,...
04/10/2024
Psych Congress NP Institute
Hoberg and Matthews
Clinical Pearls
Tolerability Testing in Long-Acting Injectable Prescriptions
04/03/2024
Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.
Do clinicians need to test for tolerability before prescribing a long-acting injectable (LAI)? Desiree Matthews, PMHNP-BC, and Amber Hoberg, MSN, APRN, PMHNP-BC, offer their clinical insight.
Do clinicians need to test for...
04/03/2024
Psych Congress NP Institute

Advertisement

Advertisement

Sign Up

Psych Congress Network Newsletter

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use